These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 6373078)
1. Antilymphocyte globulin for the treatment of steroid non-responsive acute renal allograft rejection. Griffin PJ; Williams GT; Salaman JR Clin Nephrol; 1984 Feb; 21(2):115-7. PubMed ID: 6373078 [TBL] [Abstract][Full Text] [Related]
2. One center's experience with antithymocyte globulin treatment for acute rejection in renal transplantation. Colak T; Sevmiş S; Karakayali H; Moray G; Haberal M Transplant Proc; 2008; 40(1):123-5. PubMed ID: 18261564 [TBL] [Abstract][Full Text] [Related]
3. [Treatment with antilymphocyte globulin (ALG) and evolution of renal transplant: observations of 42 cases]. Civati G; Grillo C; Di Belgioioso GB; Rovati C; Surian M; Busnach G; Broggi L; Ferrari L Boll Ist Sieroter Milan; 1978 May; 57(2):165-72. PubMed ID: 365193 [TBL] [Abstract][Full Text] [Related]
4. Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Wieneke H; Otte B; Lang D; Heidenreich S Clin Nephrol; 1996 Jan; 45(1):22-8. PubMed ID: 8616953 [TBL] [Abstract][Full Text] [Related]
5. Brequinar sodium significantly reduces the incidence of steroid-resistant rejection and resource utilization in primary renal transplant patients compared with azathioprine. Dunn JF; Hatch J; Precht A; Hart M; Li S Transplant Proc; 1996 Apr; 28(2):955-7. PubMed ID: 8623479 [No Abstract] [Full Text] [Related]
6. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569 [TBL] [Abstract][Full Text] [Related]
7. Clinical and economic outcomes of rabbit antithymocyte globulin induction in adults who received kidney transplants from living unrelated donors and received cyclosporine-based immunosuppression. Miller JT; Collins CD; Stuckey LJ; Luan FL; Englesbe MJ; Magee JC; Park JM Pharmacotherapy; 2009 Oct; 29(10):1166-74. PubMed ID: 19792990 [TBL] [Abstract][Full Text] [Related]
8. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation. Taylor HE; Ackman CF; Horowitz I Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705 [TBL] [Abstract][Full Text] [Related]
9. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids. Cantarovich D J Nephrol; 2004; 17 Suppl 8():S40-6. PubMed ID: 15599885 [TBL] [Abstract][Full Text] [Related]
11. Treatment of steroid resistant acute rejection after renal transplantation. Oh CK; Kim YS; Kim MS; Kim SI; Park K Transplant Proc; 1996 Jun; 28(3):1453-4. PubMed ID: 8658737 [No Abstract] [Full Text] [Related]
12. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M; Latter DA; Loertscher R Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721 [TBL] [Abstract][Full Text] [Related]
13. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients. Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743 [TBL] [Abstract][Full Text] [Related]